SpaMedica and Vision Express partner for UK training placement programme

News
Article

The partnership with the NHS eye patient servicer will help preregistration optometrists access training in community and hospital settings

A doctor in a white coat and a nurse in teal scrubs shake hands. Image credit: ©master1305 – stock.adobe.com

Trainees will see the company’s theatre teams perform procedures including cataract removal and vitreo-retinal surgery. Image credit: ©master1305 – stock.adobe.com

UK-based NHS eye patient servicer SpaMedica has announced a partnership with Vision Express to offer preregistration training placements for 150 aspiring optometrists. Trainees chosen for a placement will be able to shadow SpaMedica’s clinical teams and in-house optometrists as they treat patients with a variety of eye conditions, including cataracts and wet age-related macular degeneration, according to a news release.

“We know hospital placements for pre-reg optometrists can be difficult to secure due to limited availability, so we’re delighted to be working with Vision Express and The College of Optometrists to facilitate wider access to professional development and training opportunities,” said Tom Critchley, SpaMedica’s principal optometrist, in the release. “During their placements, our pre-reg trainees will gain a variety of practical skills, underpinned by theoretical modules that will help them throughout their careers.”

SpaMedica’s pre-reg training programme will be run across its nationwide network of hospitals, with trainees taking part in the cataract pre- and postoperative clinics in addition to medical retina services. Trainees will also see the company’s theatre teams perform procedures including cataract removal and vitreo-retinal surgery. Placements will last for 2 and a half days with the opportunity to attend virtual clinics with patients.

After inspection conducted by the Care Quality Commission, SpaMedica’s hospitals have been rated as “good” or “outstanding,” with 98% of patients who have reviewed the provider on the NHS website has given SpaMedica a 5-star rating.

“SpaMedica has an excellent reputation in the optical sector and our partnership will ensure pre-reg optometrists are able to access high quality training and superivison in both community and hospital settings, meeting many of the competencies outlined in the Scheme for Registration,” said Dan McGhee, director of Professional Services for EssilorLuxottica Optical Retail UK and Ireland / Vision Express UK and Ireland, in the release.

Rafeh Rehman, the first pre-reg optometrist from Vision Express, recalled the welcome he received when he started his hospital placements at SpaMedica Manchester on February 4, 2025. “It was lovely to receive such a warm welcome and I’m looking forward to gaining valuable experience and expanding my skill set,” Rehman said in the release. “It will be really interesting to get an insight into hospital optometry and I’m grateful to both Vision Express and SpaMedica for helping me on my journey to becoming a registered optometrist, ensuring I’m able to deliver the highest standard of care to my patients.”

SpaMedica plans to welcome more pre-reg optometrists in the future.

Reference:

SpaMedica launches pre-reg training program to support future generations of optometrists. News release. SpaMedica. February 11, 2025. Accessed February 12, 2025.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.